These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3358362)

  • 41. [Distribution of cis-diamminedichloroplatinum in patients with metastatic brain tumors after intravenous or intracarotid administration].
    Nakagawa H; Fujita T; Izumoto S; Kubo S; Nakajima Y; Turuzono K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):103-9. PubMed ID: 1987891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.
    Fichtinger-Schepman AM; Vendrik CP; van Dijk-Knijnenburg WC; de Jong WH; van der Minnen AC; Claessen AM; van der Velde-Visser SD; de Groot G; Wubs KL; Steerenberg PA
    Cancer Res; 1989 Jun; 49(11):2862-7. PubMed ID: 2720647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement of platinum in saliva of patients treated with cisplatin.
    Holding JD; Lindup WE; Roberts NB; Salvatori P; Stell PM
    Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():655-9. PubMed ID: 10505218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical pharmacokinetics of carboplatin.
    van der Vijgh WJ
    Clin Pharmacokinet; 1991 Oct; 21(4):242-61. PubMed ID: 1760899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
    Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Hamburger DR; Delauter BJ; Grim A; Zuhowski EG; Joseph E; Pluim D; Potter DM; Eiseman JL
    Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity.
    Gregg RW; Molepo JM; Monpetit VJ; Mikael NZ; Redmond D; Gadia M; Stewart DJ
    J Clin Oncol; 1992 May; 10(5):795-803. PubMed ID: 1569451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic Lipoplatin infusion results in preferential tumor uptake in human studies.
    Boulikas T; Stathopoulos GP; Volakakis N; Vougiouka M
    Anticancer Res; 2005; 25(4):3031-9. PubMed ID: 16080562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the anti-tumor effects of two platinum agents (miriplatin and fine-powder cisplatin).
    Watanabe S; Nitta N; Ohta S; Sonoda A; Otani H; Tomozawa Y; Nitta-Seko A; Tsuchiya K; Tanka T; Takahashi M; Murata K
    Cardiovasc Intervent Radiol; 2012 Apr; 35(2):399-405. PubMed ID: 21584842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and tumor concentration of intraarterial and intravenous cisplatin in patients with head and neck squamous cancer.
    Sileni VC; Fosser V; Maggian P; Padula E; Beltrame M; Nicolini M; Arslan P
    Cancer Chemother Pharmacol; 1992; 30(3):221-5. PubMed ID: 1628371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy.
    Tothill P; Klys HS; Matheson LM; McKay K; Smyth JF
    Eur J Cancer; 1992; 28A(8-9):1358-61. PubMed ID: 1515251
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.
    Sasaki Y; Tamura T; Eguchi K; Shinkai T; Fujiwara Y; Fukuda M; Ohe Y; Bungo M; Horichi N; Niimi S
    Cancer Chemother Pharmacol; 1989; 23(4):243-6. PubMed ID: 2647312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic artery.
    Khokhar AR; Wright K; Siddik ZH; Perez-Soler R
    Cancer Chemother Pharmacol; 1988; 22(3):223-7. PubMed ID: 3409456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9L malignant glioma.
    Nakashima M; Shibata S; Tokunaga Y; Fujita H; Anda T; Arizono K; Tomiyama N; Sasaki H; Ichikawa M
    J Pharm Pharmacol; 1997 Aug; 49(8):777-80. PubMed ID: 9379355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma.
    DeGregorio MW; King OY; Holleran WM; Wilbur BJ; Cadman EC; Deisseroth AB; Wilbur JR
    Cancer Treat Rep; 1985 Dec; 69(12):1441-2. PubMed ID: 4075318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay.
    Motzer RJ; Reed E; Perera F; Tang D; Shamkhani H; Poirier MC; Tsai WY; Parker RJ; Bosl GJ
    Cancer; 1994 Jun; 73(11):2843-52. PubMed ID: 7514956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
    Hohnloser JH; Schierl R; Hasford B; Emmerich B
    Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human autopsy tissue concentrations of mitoxantrone.
    Stewart DJ; Green RM; Mikhael NZ; Montpetit V; Thibault M; Maroun JA
    Cancer Treat Rep; 1986 Nov; 70(11):1255-61. PubMed ID: 3768871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro and in vivo evaluation of the combination of cisplatin and its analogue carboplatin for platinum dose intensification in ovarian carcinoma.
    Dittrich C; Sevelda P; Baur M; Marth C; Hudec M; Vavra N; Grunt T; Fazeny B; Salzer H
    Cancer; 1993 May; 71(10):3082-90. PubMed ID: 8490836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platinum in blood mononuclear cells from patients after cisplatin therapy.
    Sunderman FW; Sporn J; Hopfer SM; Sweeney KR; Chakraborty NG; Greenberg B
    Ann Clin Lab Sci; 1990; 20(6):379-84. PubMed ID: 2073087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of sodium thiosulfate on cisplatin removal after intra-arterial embolization with a lipiodol-platinum suspension for hepatocellular carcinoma.
    Tamura Y; Ikeda O; Nakasone Y; Iryo Y; Yamashita Y
    Acta Radiol; 2010 May; 51(4):383-8. PubMed ID: 20192896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.